Evidence map›Paper›PMID 30904393›Full record

ArticleMolecular cell2019

Retapamulin-Assisted Ribosome Profiling Reveals the Alternative Bacterial Proteome.

Sezen Meydan, James Marks, Dorota Klepacki, Virag Sharma, Pavel V Baranov, Andrew E Firth, Tōnu Margus, Amira Kefi, Nora Vázquez-Laslop, Alexander S Mankin

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 193 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Approaches for Studying Context Specificity of Translation Inhibitor Action.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Analysis of stress-induced small proteins inbioRxiv : the preprint server for biology · 2025
    Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Sezen MeydanCenter for Biomolecular Sciences-m/c 870, University of Illinois at Chicago, 900 S. Ashland Ave., Chicago, IL 60607, USA.
James MarksCenter for Biomolecular Sciences-m/c 870, University of Illinois at Chicago, 900 S. Ashland Ave., Chicago, IL 60607, USA.
Dorota KlepackiCenter for Biomolecular Sciences-m/c 870, University of Illinois at Chicago, 900 S. Ashland Ave., Chicago, IL 60607, USA.
Virag SharmaCRTD-DFG Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany; Paul Langerhans Institute Dresden of the Helmholtz Center Munich at University Hospital, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany; German Center for Diabetes Research, Munich, Neuherberg, Germany.
Pavel V BaranovSchool of Biochemistry and Cell Biology, University College Cork, Cork T12 YN60, Ireland.
Andrew E FirthDivision of Virology, Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
Tōnu MargusCenter for Biomolecular Sciences-m/c 870, University of Illinois at Chicago, 900 S. Ashland Ave., Chicago, IL 60607, USA.
Amira KefiCenter for Biomolecular Sciences-m/c 870, University of Illinois at Chicago, 900 S. Ashland Ave., Chicago, IL 60607, USA.
Nora Vázquez-LaslopCenter for Biomolecular Sciences-m/c 870, University of Illinois at Chicago, 900 S. Ashland Ave., Chicago, IL 60607, USA. Electronic address: nvazquez@uic.edu.
Alexander S MankinCenter for Biomolecular Sciences-m/c 870, University of Illinois at Chicago, 900 S. Ashland Ave., Chicago, IL 60607, USA. Electronic address: shura@uic.edu.
Ashland (United States) · USUniversity of Illinois Chicago · USUniversity College Cork · IEUniversity Hospital Carl Gustav Carus · DEUniversity of Cambridge · GB

Funding

Wellcome Trust 106207Wellcome Trust 210692Wellcome Trust 210692/Z/18/Z
6 · The paper itself

Abstract

The use of alternative translation initiation sites enables production of more than one protein from a single gene, thereby expanding the cellular proteome. Although several such examples have been serendipitously found in bacteria, genome-wide mapping of alternative translation start sites has been unattainable. We found that the antibiotic retapamulin specifically arrests initiating ribosomes at start codons of the genes. Retapamulin-enhanced Ribo-seq analysis (Ribo-RET) not only allowed mapping of conventional initiation sites at the beginning of the genes, but strikingly, it also revealed putative internal start sites in a number of Escherichia coli genes. Experiments demonstrated that the internal start codons can be recognized by the ribosomes and direct translation initiation in vitro and in vivo. Proteins, whose synthesis is initiated at internal in-frame and out-of-frame start sites, can be functionally important and contribute to the "alternative" bacterial proteome. The internal start sites may also play regulatory roles in gene expression.

Indexed as

Peptide Chain Initiation, TranslationalProteomicsBridged Bicyclo Compounds, HeterocyclicCodon, InitiatorDiterpenesEscherichia coliGene Expression Regulation, BacterialGenome, BacterialProteomeRibosomesRNA, MessengerBridged Bicyclo Compounds, HeterocyclicCodon, InitiatorDiterpenesProteomeretapamulinRNA, Messengeralternative initiationarcBinternal genesretapamulinribosome profilingrpnspeAtranslation initiation

Identifiers

PMID30904393
PMCPMC7115971
OpenAlexW2908521178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.